Much recent research on c-Myc has focused on how it drives apoptosis. c-Myc
is widely known as a crucial regulator of cell proliferation in normal and
neoplastic cells, but until relatively recently its apoptotic properties,
which appear to be intrinsic, were not fully appreciated. Its death-dealing
aspects have gained wide attention in part because of their potential ther
apeutic utility in advanced malignancy, where c-Myc is frequently deregulat
ed and where novel modalities are badly needed. Although its exact function
remains obscure, c-Myc is a transcription factor and advances have been ma
de in characterizing target genes which may mediate its apoptotic propertie
s. Candidate regulators and effecters are also emerging. Among recent findi
ngs are connections to the CD95/Fas and TNF pathways and roles for the tumo
r suppressor p19ARF and the c-Myc-interacting adaptor protein Bin1 in media
ting cell death. In this review I summarize the data establishing a role fo
r c-Myc in apoptosis in diverse settings and present a modified dual signal
model for c-Myc function. It is proposed that c-Myc induces apoptosis thro
ugh separate 'death priming' and 'death triggering' mechanisms in which 'de
ath priming' and mitogenic signals are coordinated. Investigation of the me
chanisms that underlie the triggering steps may offer new therapeutic oppor
tunities.